fbpx

Tag Index  /  Showing 1 - 4 of 4 results for “genome sequencing”

Bio & Life Sciences

How an Entrepreneur Tackled a Rare Disease: A Conversation with Matt Wilsey

Matt and Kristen Wilsey consulted more than 100 doctors and scientists to identify their daughter Grace’s rare disease, persisting when suggested diagnoses didn’t seem quite right or when doctors had no answers at all. Finally genome sequencing ended their diagnostic odyssey—and made them crusaders for a better approach.   More

Bio & Life Sciences

DNA Diagnosis Works, But It’s Not Likely to Cure You Soon

At a recent scientific meeting for researchers working with DNA sequencing tools, Joe DeRisi from the University of California, San Francisco, gave a riveting presentation about the medical case of a young boy with acute encephalitis. The talk offered a glimpse into the tremendous clinical potential for DNA sequencing—and simultaneously highlighted just how far this technology still is from the mainstream. DeRisi is known for a major coup in 2003 when he led the first American team to identify SARS. At the time, the coronavirus was still an unknown terror sweeping across Asia. His lab focuses on identifying pathogens, which is how DeRisi got involved in the case of the young boy with encephalitis.   More

Bio & Life Sciences

Should You Have the Right Not to Know Genetic Information?

Affordable genome sequencing has brought with it a host of ethical debates. Who owns the data? Who can access the data? Should we sequence children? But the debate most likely to directly affect you in the next few years is this: what happens if your physician has your genome sequenced and finds something that she wasn’t looking for?   More

Bio & Life Sciences

Life Sciences: What to Expect in 2013

It’s still early enough in the year that we’re all still reminding ourselves to write “2013” instead of “2012”—which means that it’s just the right time to be considering what this new year has in store for us. Every news service loves to make predictions, and here at Techonomy we’re no different. So here are our best guesses for what’s to come for the life sciences field in 2013.   More